Sonnet BioTherapeutics

Princeton, United States

Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.

$3.9M raised

Dec 2024

Post-IPO Equity

Biotechnology Health Care Pharmaceutical Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sonnet BioTherapeutics

How much funding has Sonnet BioTherapeutics raised?

Sonnet BioTherapeutics has raised $3.9M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in December 2024.

Where is Sonnet BioTherapeutics headquartered?

Sonnet BioTherapeutics is headquartered in Princeton, United States.

What does Sonnet BioTherapeutics do?

Sonnet BioTherapeutics is a biotechnology company for innovating biologic drugs of the single or bispecific mechanism of action.

What stage is Sonnet BioTherapeutics at?

Sonnet BioTherapeutics is at the Post-IPO Equity stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 9, 2024.

MLA

"Sonnet BioTherapeutics — Funding & Investors." VCBacked, December 9, 2024, https://www.vcbacked.co/company/sonnet-biotherapeutics. Accessed July 2, 2026.

APA

VCBacked. (2024). Sonnet BioTherapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/sonnet-biotherapeutics

Wikipedia (cite web)

{{cite web |title=Sonnet BioTherapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sonnet-biotherapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 9, 2024.